Tianxin Yang

1.6k total citations
30 papers, 1.2k citations indexed

About

Tianxin Yang is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Tianxin Yang has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Toxicology. Recurrent topics in Tianxin Yang's work include Cancer-related Molecular Pathways (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Tianxin Yang is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Tianxin Yang collaborates with scholars based in China, United States and Australia. Tianxin Yang's co-authors include Xueji Zhang, Zhi-Wei Zhou, Shu-Feng Zhou, Zhi-Xu He, Wei Duan, Zheng Dong, Cong‐Yi Wang, Yinxue Yang, Craig R. Brooks and Sung-Gyu Cho and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Tianxin Yang

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianxin Yang China 21 671 170 170 141 132 30 1.2k
Claudia von Montfort Germany 21 515 0.8× 65 0.4× 188 1.1× 268 1.9× 101 0.8× 34 1.2k
Brice Sid Belgium 20 656 1.0× 133 0.8× 44 0.3× 158 1.1× 45 0.3× 21 1.1k
Simran S. Sabharwal United States 5 930 1.4× 197 1.2× 140 0.8× 115 0.8× 212 1.6× 8 1.6k
Felicia Fei‐Lei Chung Malaysia 21 737 1.1× 327 1.9× 60 0.4× 60 0.4× 112 0.8× 44 1.3k
Dahong Yao China 19 644 1.0× 143 0.8× 67 0.4× 155 1.1× 58 0.4× 58 1.2k
Amit Deorukhkar United States 18 953 1.4× 263 1.5× 152 0.9× 53 0.4× 339 2.6× 34 1.8k
James M. Jamison United States 23 550 0.8× 84 0.5× 87 0.5× 110 0.8× 39 0.3× 69 1.4k
Gernot Bruchelt Germany 22 653 1.0× 184 1.1× 71 0.4× 108 0.8× 79 0.6× 85 1.5k
Ľuba Hunáková Slovakia 20 726 1.1× 291 1.7× 51 0.3× 70 0.5× 79 0.6× 91 1.5k

Countries citing papers authored by Tianxin Yang

Since Specialization
Citations

This map shows the geographic impact of Tianxin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianxin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianxin Yang more than expected).

Fields of papers citing papers by Tianxin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianxin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianxin Yang. The network helps show where Tianxin Yang may publish in the future.

Co-authorship network of co-authors of Tianxin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Tianxin Yang. A scholar is included among the top collaborators of Tianxin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianxin Yang. Tianxin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Tianxin, et al.. (2022). New Approaches for Treatment of Advanced Extranodal NK/T-Cell Lymphoma. SHILAP Revista de lepidopterología.
2.
Yang, Tianxin, Tengfei Zhang, Qi Chen, et al.. (2019). Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload. Proceedings of the National Academy of Sciences. 116(39). 19635–19645. 69 indexed citations
3.
Xue, Danfeng, Zhi-Wei Zhou, Zhi-Xu He, et al.. (2016). Computational Identification of the Paralogs and Orthologs of Human Cytochrome P450 Superfamily and the Implication in Drug Discovery. International Journal of Molecular Sciences. 17(7). 1020–1020. 22 indexed citations
4.
Yan, Lu, Tengfei Zhang, Yue Shi, et al.. (2016). PFR peptide, one of the antimicrobial peptides identified from the derivatives of lactoferrin, induces necrosis in leukemia cells. Scientific Reports. 6(1). 20823–20823. 47 indexed citations
5.
Zhou, Zhi-Wei, Tianxin Yang, Wei Duan, et al.. (2016). Inhibition of Aurora kinases induces apoptosis and autophagy via AURKB/p70S6K/RPL15 axis in human leukemia cells. Cancer Letters. 382(2). 215–230. 36 indexed citations
6.
Zhou, Shu‐Feng, Yi Zhang, Zhiwei Zhou, et al.. (2015). Schisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: implications for its hepatotoxicity. Drug Design Development and Therapy. 9. 2001–2001. 23 indexed citations
7.
8.
Li, Jin-Ping, Qilun Liu, Zhixue He, et al.. (2015). The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells. Drug Design Development and Therapy. 9. 1027–1027. 30 indexed citations
9.
Zhou, Shu-Feng, Juanjuan Yin, Zhi-Wei Zhou, et al.. (2015). Controllable drug uptake and nongenomic response through estrogen-anchored cyclodextrin drug complex. International Journal of Nanomedicine. 10. 4717–4717. 3 indexed citations
10.
Zhou, Zhi-Wei, Kevin Sneed, Xueji Zhang, et al.. (2015). Clinical Association Between Pharmacogenomics and Adverse Drug Reactions. Drugs. 75(6). 589–631. 49 indexed citations
11.
Zhou, Shu‐Feng, Shuting Pan, Yiru Qin, et al.. (2015). Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells. Drug Design Development and Therapy. 9. 5511–5511. 36 indexed citations
12.
Yang, Tianxin, Jianping Lan, Qiang Huang, et al.. (2014). Embelin Sensitizes Acute Myeloid Leukemia Cells to TRAIL through XIAP Inhibition and NF-κB Inactivation. Cell Biochemistry and Biophysics. 71(1). 291–297. 25 indexed citations
13.
14.
He, Zhi-Xu, Minghua Li, Yinxue Yang, et al.. (2013). Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells. Cancer Letters. 344(2). 239–259. 128 indexed citations
15.
16.
Brooks, Craig R., Sung-Gyu Cho, Cong‐Yi Wang, Tianxin Yang, & Zheng Dong. (2010). Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis. American Journal of Physiology-Cell Physiology. 300(3). C447–C455. 126 indexed citations
17.
Huang, Songming, Aihua Zhang, Qiuxia Chen, et al.. (2009). Y-Box Protein 1 Stimulates Mesangial Cell Proliferation via Activation of ERK1/2. Nephron Experimental Nephrology. 113(1). e16–e25. 16 indexed citations
18.
Chen, Qiuxia, Songming Huang, Aihua Zhang, et al.. (2009). Suppression Subtractive Hybridization Analysis of Gene Expression during Late Kidney Development Identifies the Developmentally Regulated Gene <i>rPEA3</i>. Nephron Experimental Nephrology. 111(4). e103–e115. 4 indexed citations
19.
Dong, Guie, et al.. (2008). Induction of Apoptosis in Renal Tubular Cells by Histone Deacetylase Inhibitors, a Family of Anticancer Agents. Journal of Pharmacology and Experimental Therapeutics. 325(3). 978–984. 37 indexed citations
20.
Zhang, Aihua, Guixia Ding, Songming Huang, et al.. (2005). c-Jun NH2-terminal kinase mediation of angiotensin II-induced proliferation of human mesangial cells. American Journal of Physiology-Renal Physiology. 288(6). F1118–F1124. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia von Montfort Breakdown of academic impact, for papers by Brice Sid Breakdown of academic impact, for papers by Simran S. Sabharwal Breakdown of academic impact, for papers by Felicia Fei‐Lei Chung Breakdown of academic impact, for papers by Dahong Yao Breakdown of academic impact, for papers by Amit Deorukhkar Breakdown of academic impact, for papers by James M. Jamison Breakdown of academic impact, for papers by Gernot Bruchelt Breakdown of academic impact, for papers by Ľuba Hunáková
Rankless by CCL
2026